Back to Search
Start Over
MYOD1 as a prognostic indicator in rhabdomyosarcoma
- Source :
- Pediatr Blood Cancer
- Publication Year :
- 2021
-
Abstract
- BACKGROUND/OBJECTIVES: Rhabdomyosarcoma (RMS) is characterized by the expression of the myogenic regulatory protein MYOD1. Histologic types include alveolar, embryonal (ERMS), and spindle cell sclerosing RMS (SRMS). SRMS harbors MYOD1 mutations in a subset of adult cases in association with poor prognosis. DESIGN/METHODS: To study the level of MYOD1 protein expression and its clinical significance, we have analyzed variable numbers of pediatric (
- Subjects :
- Oncology
Adult
medicine.medical_specialty
Poor prognosis
animal structures
genetic structures
Adolescent
Protein expression
Article
03 medical and health sciences
Young Adult
0302 clinical medicine
Internal medicine
Rhabdomyosarcoma
medicine
Overall survival
Histologic type
Humans
Clinical significance
Rhabdomyosarcoma, Embryonal
Child
Rhabdomyosarcoma, Alveolar
MyoD Protein
business.industry
Infant
Hematology
medicine.disease
Prognosis
030220 oncology & carcinogenesis
embryonic structures
Pediatrics, Perinatology and Child Health
Mutation
Immunohistochemistry
business
030215 immunology
Subjects
Details
- ISSN :
- 15455017
- Volume :
- 68
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- Pediatric bloodcancerREFERENCES
- Accession number :
- edsair.doi.dedup.....2740452d814de9edb3e742bdab93742a